IPEL ITIBANYL

Sao Paulo, Brazil Acquired By LANXESS
Biocidal ingredients and formulations are manufactured by IPEL ITIBANYL.

About IPEL ITIBANYL

IPEL ITIBANYL is a Chemicals & Materials company based in Sao Paulo (Brazil), and was acquired by LANXESS in November 2019. Biocidal ingredients and formulations are manufactured by IPEL ITIBANYL. Its chief executive, as recorded, is Eliane Siviero. IPEL ITIBANYL offers products and services including Biocides and Microbial Control Solutions. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.

Company details

IPEL ITIBANYL manufacturer of biocidal ingredients and formulations through chemicals and materials, diversified chemicals, and diversified. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Sao Paulo, Brazil
  • Stage Acquired
  • Sectors
    Chemicals & Materials
  • Website ipel.com.br
  • Social LinkedIn
  • Acquired by LANXESS (Nov 2019)
Key Metrics

Products & Services of IPEL ITIBANYL

IPEL ITIBANYL offers a comprehensive portfolio of products and services, including Biocides and Microbial Control Solutions.

Biocides
Chemical Products

Formulations for controlling microbial growth in industrial applications

Microbial Control Solutions
Environmental Protection

Products that prevent contamination in construction and water sectors

Investors in IPEL ITIBANYL

IPEL ITIBANYL has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LANXESS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Chemical company
1981lanxess.comCologne, Germany
Premium access

Investor details for IPEL ITIBANYL

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of IPEL ITIBANYL

1 people are tracked at IPEL ITIBANYL (1 in leadership).

NameRoleGroup
Eliane Siviero
CEOLeadership
Premium access

Complete people profiles for IPEL ITIBANYL

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ipel Itibanyl

Premium access

Complete news archive for IPEL ITIBANYL

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about IPEL ITIBANYL

IPEL ITIBANYL is headquartered in Sao Paulo, Brazil.

Eliane Siviero is the CEO of IPEL ITIBANYL, as recorded in our data.

IPEL ITIBANYL manufacturer of biocidal ingredients and formulations through chemicals and materials, diversified chemicals, and diversified. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

IPEL ITIBANYL offers Biocides and Microbial Control Solutions.

IPEL ITIBANYL has 1 investor. Key investors include LANXESS.

Yes. IPEL ITIBANYL was acquired by LANXESS in November 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available